The cerebrospinal fluid (CSF) of normal humans contains both true and pseudocholinesterases and choline acetyl transferase (choline acetylase) detectable by radiochemical assay. Elevations of total cholinesterase, pseudocholinesterase, and true cholinesterase occur in brain tumors, meningitis, Guillain-Barre disease, hydrocephalus, and brain abscess. However, the non-specificity and inconstancy of CSF cholinesterase changes in neurologic diseases limit its clinical usefulness.
The cerebrospinal fluid (CSF) of normal humans contains both true and pseudocholinesterases and choline acetyl transferase (choline acetylase) detectable by radiochemical assay. Elevations of total cholinesterase, pseudocholinesterase, and true cholinesterase occur in brain tumors, meningitis, Guillain-Barre disease, hydrocephalus, and brain abscess. However, the non-specificity and inconstancy of CSF cholinesterase changes in neurologic diseases limit its clinical usefulness.
Choline acetylase levels in CSF are normally 0.187 * 0.073 nmoles ACh/ml CSF/ min. One patient with meningioma had a level of 0.680. Unlike cholinesterase, choline acetylase levels in blood are lower than in CSF. Hence, the origin of elevated CSF choline acetylase activity is probably in the nervous system.
Ih'TRODUCTION
Measurement of serum enzymes provides a useful diagnostic clue in patients with hepatitis, myocardial infarction, muscular dystrophy, and other somatic diseases. By analogy, one might expect enzymes released into the cerebrospinal fluid (CSF) from the brain to help in the diagnosis of neurologic diseases. However, assay of spinal fluid enzymes has not gained widespread clinical acceptance.
Earlier studies of CSF enzymes have been criticized because the origin of these enzymes is not clear.
We have reexamined CSF cholinesterases, reviewed previous reported changes in CSF cholinesterase in diseases of the nervous system, and sought further correlations between cholinesterases and neurologic disease. In addition, we applied a similar approach to the enzyme choline acetylase (choline acetyltransferase) which, to our knowledge, has not previously been measured in human CSF. Since iso-OMPA also inhibits acetylcholinesterase somewhat, our values are lower than previously reported activities (see Table I ). Rutyrylcholinesterase ("pseudocholinesterase") activity was determined with [I-%-butyrylcholine substrate plus IO-~ M R.W. 28451, a true cholinesterase inhibitor. Samples of CSF were assayed in batches. Mean storage time of samples was 15 days, a maximum storage time was 33 days in one instance. Fig. I shows that a slight loss of cholinesterase activity did occur in storage at -25' C. However, mean storage time of the samples in the various diagnostic categories did not significantly differ.
Choline acetylase
Choline acetylase was assayed by a radiochemical method based on the work of McCaman and Hunt2 and Schrier and Shuster3. In this assay, choline acetylase forms acetylcholine from excess choline (IO-~ M) and 14C-labelled acetyl-coenzyme A (6.25
10-4 M, 20 ooo cpm). The labeled acetylcholine formed was separated on prewashed 8 cm Dowex 1-X8 Cl (200-400 mesh) columns. The purified acetylcholine radioactivity was determined on a scintillation counter. Since the CSF contains only small amounts of choline acetylase activity, samples were concentrated IO times by lyophilization before assay. Aliquots of pooled CSF from 25 patients were run with each batch of choline acetylase assays to control the uniformity of the procedure.
Loss of rat brain homogenate choline acetylase activity with storage is also shown in Fig. I . Mean storage time of samples was 65 days, ranging from 14 to 99 days. Mean storage times of samples in the various diagnostic categories did not significantly differ.
Proteilz
Cerebrospinal fluid protein was determined by the method of Lowry et a1.4
Cerebrospinal juid Cerebrospinal fluid was obtained from three sources :(a) patients with neurologic diseases had lumbar punctures performed by the clinical staff of the Neurology,
Neurosurgery
and Pediatrics Departments. The fluid was kept refrigerated for a maximum of 48 h at 4' before freezer storage at -25'.
(1~) CSF was obtained at pneumoencephalography to determine if any relationship existed between the amount of fluid withdrawn, the protein concentration, and enzyme activity. With the patient sitting, serial samples of fluid were withdrawn as increasing amounts of air were injected. CSF not needed for other clinical measurements was saved for enzyme analysis. (c) Five samples of 2 ml CSF from normal volunteers was obtained through the courtesy of Professor W. W. Tourtelotte of the Neurology Department. Samples of 20 ml CSF were obtained by lumbar puncture at the rate of I ml/min. The samples were spun down and the supernatant frozen at -80" in I ml aliquots. The samples had been frozen 8 months at the time of assay.
JOHNSON, DOMINO DIAGNOSTIC CATEGORIES
Patients were assigned to diagnostic categories according to information obtained from their hospital records. The following criteria were used:
(I) Normal controls : (a) CSF from 5 normal college student volunteers courtesy of \\'.U:.T. (see above). The students had a normal review of systems, no history of metabolic, neurologic, or other disease, and no history of drug abuse. They had normal neurologic examinations, CSI; cell counts, VDRL's, and CSF protein levels. This group was used for choline acetylase assays only. (b) In patients who had had extensive clinical and laboratory workups, but who had no pathologic findings, or at most a diagnosis of "neurosis."
(2) Hydrocephalus : Bulging fontanelle, head circumference two standard deviations or more above normal for age, signs of increased intracranial pressure, on ventriculography no sign of a mass or lesion.
(3) Multiple sclerosis: Evidence of multiple central nervous system (CNS) lesions both spatially and temporally, usually including retrobulbar neuritis.
(4) Senile dementia: Signs of disorientation and loss of recent memory in a person over 50 years old. On pneumoencephalography, cortical atrophy and/or ventricular dilatation were present but no evidence of a mass or lesion. The other diagnoses were made by the clinical staff at University Hospital, but full diagnostic details will not be given.
RESULTS

Surprisingly,
cholinesterase activity in the CSF did not vary with CSP total protein nor with the amount of CSF withdrawn (up to 30 ml) in a patient with cerebellar atrophy. Vie obtained similar results in a patient with multiple sclerosis, one with senile dementia, and one who developed thalamic pain two years after a stroke. In a fifth patient who had psychomotor epilepsy, the graph showed a rough correlation between butyrylcholinesterase activity and total protein, but a coefficient of correlation was not significant. Hence, we express CSF cholinesterase activity per unit volume of CSF. Fig. 2 shows graphically the relationships among the amount of CSF withdrawn, the choline acetylase activity and the total protein concentration in CSF in a patient with senile dementia. Choline acetylase activity which is extremely low in CSF seems to vary with total protein concentration.
In another patient who had multiple sclerosis, the choline acetylase activity appeared to vary with the protein, too. The coefficient of correlation between protein and choline acetylase activity was not significant using data from only two patients, however. Hence, we have expressed choline acetylase activity both per ml of CSF and per mg CSF protein. Table II pseudocholinesterase is found predominantly in glial cells and in serum-*. Studies on pathological specimens reveal decreased cholinesterase activity in multiple sclerotic plaque9 and increased pseudocholinesterase activity in brain tumor tissue'". Cholinesterase in CSF might originate from any of these sites.
Concerning possible sampling variations in CSF cholinesterase activity, our data show remarkably constant activity, whether the first or the 33th ml of CSE withdrawn is assayed. Surprisingly, our data show that CSF cholinesterase activity and total protein vary independently.
Colling and Rossiterll reported a significant correlation between pseudocholinesterase activity and total CSF protein. Jeffersoni and Tower and MacEacllern13 reported correlation between pseudocholinesterase and total protein only when total protein levels are greater than 50 mg"/. To explain the apparent contradiction, note that cholinesterase has one of the highest substrate turnover numbers of any enzyme. Thus, cholinesterase activity could change greatly with little increase in total protein. Furthermore, Colling and Rossiter's report included many cases of meningitis, where the blood-cerebrospinal fluid barrier is known to have increased permeability to plasma proteins. Influx of plasma protein, which contains high pseudocholinesterase activity, would account for a simultaneous rise and a significant correlation between the two.
The number of cells in the CSF has little effect on cholinesterase activity. Leukocytes have insignificant cholinesterase levels 14y15. Birkhauserlc, Collin and Rossiter", and Tower and MacEacllern13 observed no correlation between cholinesterase activity and CSF leukocyte counts. Similarly, Tower and MacEachern13 observed no relationship between CSF erythrocyte counts and cholinesterase activity. A theoretical Clin. Chim. Acta, 3.j (1971) Despite a theoretical framework to account for changes in CSF cholinesterase, the practical signi~cance of the changes is minimal. Cholinesterase elevations in disease states are either non-specific or do not occur in enough of the patients with the disease to be of help in diagnosis. In a large number of neurological and psychiatric diseases, cholinesterase activity is norma111~'7~**~2"-25. Choline acetylase is present in cerebrospinal fluid, but in very much smaller quantity than cholinesterase. The ratio of normal mean enzyme levels in CSF is about I part choline acetylase to IOO parts cholinesterase.
When levels are expressed as enzyme activity per mg protein, the ratios of brain enzyme to CSF enzyme are surprisingly similar for cholinesterase and choline acetylase. The average cortical total cholinesterase is 152, and the caudate nucleus total cholinesterase 7,602 ~1 CO,/g wet brain/10 min, as reported by Okinaka et al. 5. Bull et aLz6 reported choline acetylase activity of 190 in gray matter of cortical area 4, and 3790 ,ug ACh/g fresh brain/h in = 0.14, caudate/cortex = 50. That these ratios are so similar suggests that both enzymes normally reach the spinal fluid from the same source, probably brain tissue. However, unlike cholinesterase, choline acetylase is not found in high concentrations in serum and erythrocytes. Using the same assay method as for CSI;, we found that serum choline acetylase activity is about the same or less than that in CSF, while erythrocyte activity is about twice as high as CS1; activity. Hence, blood is not an important source of elevated CSIT choline acetylase activity.
The results in Table II demonstrate that choline acetylase is normally present in CSF and that it can be elevated in patients with neurologic disease. Its clinical usefulness, if any, awaits the findings of elevated CSl; choline acetylase in a neurologic disease not better diagnosed by other methods. Neurologic diseases involving active destruction of brain tissue might be expected to show higher than normal CSF choline acetylase activity.
